概述

  • 产品名称Anti-IL27抗体
    参阅全部 IL27 一抗
  • 描述
    兔多克隆抗体to IL27
  • 特异性ab118910 recognize IL27A (NP_663634).
  • 经测试应用适用于: WB, ELISA, IHC-Pmore details
  • 种属反应性
    与反应: Human
    预测可用于: Mouse
  • 免疫原

    Synthetic peptide conjugated to KLH, corresponding to 14 amino acids from near the center of Human IL27.

  • 阳性对照
    • Daudi lysate, Human Spleen Neutrophils tissue

性能

应用

Our Abpromise guarantee covers the use of ab118910 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
WB Use a concentration of 2 - 4 µg/ml. Predicted molecular weight: 27 kDa.
ELISA Use at an assay dependent concentration.
IHC-P Use a concentration of 5 µg/ml. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

靶标

  • 功能Cytokine with pro- and anti-inflammatory properties, that can regulate T helper cell development, suppress T-cell proliferation, stimulate cytotoxic T cell activity, induce isotype switching in B-cells, and that has diverse effects on innate immune cells. Among its target cells are CD4 T helper cells which can differentiate in type 1 effector cells (TH1), type 2 effector cells (TH2) and IL17 producing helper T-cells (TH17). It drives rapid clonal expansion of naive but not memory CD4 T-cells. It also strongly synergizes with IL-12 to trigger interferon-gamma/IFN-gamma production of naive CD4 T-cells, binds to the cytokine receptor WSX-1/TCCR which appears to be required but not sufficient for IL-27-mediated signal transduction. IL-27 potentiate the early phase of TH1 response and suppress TH2 and TH17 differentiation. It induces the differentiation of TH1 cells via two distinct pathways, p38 MAPK/TBX21- and ICAM1/ITGAL/ERK-dependent pathways. It also induces STAT1, STAT3, STAT4 and STAT5 phosphorylation and activates TBX21/T-Bet via STAT1 with resulting IL12RB2 up-regulation, an event crucial to TH1 cell commitment. It suppresses the expression of GATA3, the inhibitor TH1 cells development. In CD8 T-cells, it activates STATs as well as GZMB. IL-27 reveals to be a potent inhibitor of TH17 cell development and of IL-17 production. Indeed IL-27 subunit p28 alone is also able to inhibit the production of IL17 by CD4 and CD8 T-cells. While IL-27 suppressed the development of proinflammatory Th17 cells via STAT1, it inhibits the development of anti-inflammatory inducible regulatory T-cells, iTreg, independently of STAT1. IL-27 has also an effect on cytokine production, it suppresses proinflammatory cytokine production such as IL2, IL4, IL5 and IL6 and activates suppressors of cytokine signaling such as SOCS1 and SOCS3. Apart from suppression of cytokine production, IL-27 also antagonizes the effects of some cytokines such as IL6 through direct effects on T cells. Another important role of IL-27 is its antitumor activity as well as its antiangiogenic activity with activation of production of antiangiogenic chemokines such as IP-10/CXCL10 and MIG/CXCL9. In vein endothelial cells, it induces IRF1/interferon regulatory factor 1 and increase the expression of MHC class II transactivator/CIITA with resulting up-regulation of major histocompatibility complex class II. IL-27 also demonstrates antiviral activity with inhibitory properties on HIV-1 replivation.
  • 组织特异性Expressed in monocytes and in placenta.
  • 序列相似性Belongs to the IL-6 superfamily.
  • 翻译后修饰O-glycosylated.
  • 细胞定位Secreted. Does not seem to be secreted without coexpression of EBI3.
  • Information by UniProt
  • 数据库链接
  • 别名
    • EBI3 antibody
    • IL 27 antibody
    • IL 27 p28 subunit antibody
    • IL 27A antibody
    • IL 30 antibody
    • IL-27 subunit alpha antibody
    • IL-27-A antibody
    • IL27 antibody
    • IL27-A antibody
    • IL27A antibody
    • IL27A_HUMAN antibody
    • IL27p28 antibody
    • IL30 antibody
    • Interleukin 27 antibody
    • Interleukin 27 subunit alpha antibody
    • Interleukin 27, 28-KD subunit antibody
    • Interleukin 30 antibody
    • Interleukin-27 subunit alpha antibody
    • p28 antibody
    see all

Anti-IL27 antibody 图像

  • Lane 1 : Anti-IL27 antibody (ab118910) at 2 µg/ml
    Lane 2 : Anti-IL27 antibody (ab118910) at 4 µg/ml

    Lane 1 : Daudi lysate
    Lane 2 : Daudi lysate


    Predicted band size : 27 kDa
  • Human Spleen, Neutrophils (formalin-fixed, paraffin-embedded) stained with ab118910 at 5 ug/ml followed by biotinylated goat anti-rabbit IgG secondary antibody, alkaline phosphatase-streptavidin and chromogen.

Anti-IL27 antibody (ab118910)参考文献

This product has been referenced in:
  • Di Meo S  et al. Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stage. Clin Cancer Res 20:585-94 (2014). Human . Read more (PubMed: 24277453) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab118910.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"